Your account is not claimed yet. You can sign up with ORCID to claim your account.

Thomas Hentrich

ResearcherID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Induced Pluripotent Stem Cells

Top Venues

Journal of clinical medicine

Disease models & mechanisms

Universitätsklinikum Tübingen

University of British Columbia (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitätsklinikum Tübingen

Germany

Bioinformatician in neuro-transcriptomics / -epigenomics; PostDoc :: Medical Genetics and Applied Genomics

Education History

University of British Columbia

Canada

PHD :: Computer Science

Publications

Sara Y Brucker, Thomas Hentrich, Julia M Schulze-Hentrich, Martin Pietzsch, Noel Wajngarten, Anjali Ralhan Singh, Katharina Rall, André Koch
Endometrial organoids derived from Mayer-Rokitansky-Küster-Hauser syndrome patients provide insights into disease-causing pathways. Disease models & mechanisms 15 (5) (2022)
Rebecca Buchert, Elisabeth Schenk, Thomas Hentrich, Nico Weber, Kristin Katharina Rall, Marc Sturm, Oliver Kohlbacher, André Koch, Olaf H Rieß, Sara Yvonne Brucker, Julia M Schulze-Hentrich
Genome Sequencing and Transcriptome Profiling in Twins Discordant for Mayer-Rokitansky-Küster-Hauser Syndrome. Journal of clinical medicine 11 (19) (2022)
Kathy-Ann Secker, Lukas Bruns, Hildegard Keppeler, Johan Jeong, Thomas Hentrich, Julia M Schulze-Hentrich, Barbara Mankel, Falko Fend, Dominik Schneidawind, Corina Schneidawind
Only Hematopoietic Stem and Progenitor Cells from Cord Blood Are Susceptible to Malignant Transformation by MLL-AF4 Translocations. Cancers 12 (6) (2020)
Kathy-Ann Secker, Bianca Bloechl, Hildegard Keppeler, Silke Duerr-Stoerzer, Hannes Schmid, Dominik Schneidawind, Johan Jeong, Thomas Hentrich, Julia M Schulze-Hentrich, Corina Schneidawind
MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis. Cancers 12 (5) (2020)